Maternal plasma DHA levels increase prior to 29 days post-LH surge in women undergoing frozen embryo transfer: a prospective, observational study of human pregnancy by Meyer, Barbara J et al.
University of Wollongong
Research Online
Faculty of Science, Medicine and Health - Papers Faculty of Science, Medicine and Health
2016
Maternal plasma DHA levels increase prior to 29
days post-LH surge in women undergoing frozen
embryo transfer: a prospective, observational study
of human pregnancy
Barbara J. Meyer
University of Wollongong, bmeyer@uow.edu.au
Christopher C. Onyiaodike
University of Glasgow
Elizabeth A. Brown
University of Glasgow
Fiona Jordan
University of Glasgow
Heather Murray
University of Glasgow
See next page for additional authors
Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library:
research-pubs@uow.edu.au
Publication Details
Meyer, B. J., Onyiaodike, C. C., Brown, E. Ann., Jordan, F., Murray, H., Nibbs, R. JB., Sattar, N., Lyall, H., Nelson, S. M. & Freeman, D.
J. (2016). Maternal plasma DHA levels increase prior to 29 days post-LH surge in women undergoing frozen embryo transfer: a
prospective, observational study of human pregnancy. Journal of Clinical Endocrinology and Metabolism, 101 (4), 1745-1753.
Maternal plasma DHA levels increase prior to 29 days post-LH surge in
women undergoing frozen embryo transfer: a prospective, observational
study of human pregnancy
Abstract
Context: Docosahexaenoic acid (DHA) is an important fatty acid required for neurological development but
its importance during early fetal neurological organogenesis is unknown. Objective: To assess plasma fatty
acid changes in early pregnancy in women undergoing natural cycle-frozen embryo transfer as a means of
achieving accurately-timed periconceptual sampling. Design: Women undergoing frozen embryo transfer
were recruited and serial fasting blood samples were taken pre-luteinising hormone (LH) surge, and at days
18, 29 and 45 post-LH surge and fatty acids were analysed using gas chromatography. Setting: Assisted
Conception Unit, Glasgow Royal Infirmary, Scotland Main outcome measures: Plasma fatty acid
concentrations, influence of twin pregnancies on DHA plasma concentration. Results: In pregnant women,
there was a rapid, early increase in the maternal rate of change of plasma DHA concentration observed by 29
days post-LH surge (mean±SD, from 0.1±1.3 to 1.6±2.9 nmol DHA per mL plasma per day). This early
pressure to increase plasma DHA concentration was further emphasised in twin pregnancies where the
increase in DHA concentration over 45 days was two-fold higher than in singleton pregnancies (mean±SD
increase, 74±39 nmol/mL versus 36±40 nmol/mL). An index of delta-6 desaturase activity increased 30%
and positively correlated with the rate of change of DHA concentration between day 18 and 29-post LH surge
(R-squared adjusted = 41%, P=0.0002). DHA was the only fatty acid with a continual accelerated increase in
plasma concentration and a positive incremental area under the curve (mean±SD, 632±911 nmol/mL x day)
over the first 45 days of gestation. Conclusions: An increase in maternal plasma DHA concentration is
initiated in human pregnancy prior to neural tube closure which occurs at 28 days' gestation.
Disciplines
Medicine and Health Sciences | Social and Behavioral Sciences
Publication Details
Meyer, B. J., Onyiaodike, C. C., Brown, E. Ann., Jordan, F., Murray, H., Nibbs, R. JB., Sattar, N., Lyall, H.,
Nelson, S. M. & Freeman, D. J. (2016). Maternal plasma DHA levels increase prior to 29 days post-LH surge
in women undergoing frozen embryo transfer: a prospective, observational study of human pregnancy. Journal
of Clinical Endocrinology and Metabolism, 101 (4), 1745-1753.
Authors
Barbara J. Meyer, Christopher C. Onyiaodike, Elizabeth A. Brown, Fiona Jordan, Heather Murray, Robert JB
Nibbs, Naveed Sattar, Helen Lyall, Scott M. Nelson, and Dilys J. Freeman
This journal article is available at Research Online: http://ro.uow.edu.au/smhpapers/3486
1 
 
Maternal plasma DHA levels increase prior to 29 days post-LH surge in women undergoing 
frozen embryo transfer: a prospective, observational study of human pregnancy 
 
1Barbara J Meyer, 2Christopher C Onyiaodike, 3E Ann Brown, 3Fiona Jordan, 4Heather Murray, 
5Robert JB Nibbs, 3Naveed Sattar, 2Helen Lyall, 2Scott M Nelson, 3 Dilys J Freeman. 
 
1School of Medicine, University of Wollongong, Wollongong, NSW 2522, Australia (BJ Meyer, 
PhD), 
2School of Medicine, University of Glasgow, Glasgow G12 8QQ, UK (CC Onyiaodike PhD, H Lyall 
MBChB, SM Nelson MBChB, PhD), 
3Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, UK 
(EA Brown HNC, F Jordan MSc, N Sattar MBChB, PhD, DJ Freeman PhD), 
4Robertson Centre for Biostatistics, University of Glasgow, Glasgow G12 8QQ, UK (H Murray BSc), 
5Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8QQ, UK 
(RJB Nibbs PhD). 
 
Abbreviated title: DHA and neurodevelopment in very early human pregnancy 
Key terms: DHA, maternal fatty acid changes, neural tube closure 
Word Count: 3,600 
 
Corresponding author and person to whom reprint requests should be addressed: 
A/Prof Barbara Meyer, PhD  
School of Medicine, Faculty of Science, Medicine and Health 
University of Wollongong 
Northfields Ave, Wollongong, NSW, 2522 Australia 
Phone: +61 2 4221 3459 
Fax: +61 2 4221 5945 
Email: bmeyer@uow.edu.au 
2 
 
 
Funding: Wellbeing of Women project grant RG939/07. Carnegie Award 2010, Harold Hyam 
Wingate Medical Research Travel Grant 2010. University of Wollongong Study Leave Assistance 
Grant 2012. 
 
DISCLOSUE STATEMENT: The authors have nothing to disclose 
 
  
3 
 
Abstract 
Context: Docosahexaenoic acid (DHA) is an important fatty acid required for neurological 
development but its importance during early fetal neurological organogenesis is unknown.  
Objective: To assess plasma fatty acid changes in early pregnancy in women undergoing natural 
cycle-frozen embryo transfer as a means of achieving accurately-timed periconceptual sampling. 
Design: Women undergoing frozen embryo transfer were recruited and serial fasting blood samples 
were taken pre-luteinising hormone (LH) surge, and at days 18, 29 and 45 post-LH surge and fatty 
acids were analysed using gas chromatography.  
Setting: Assisted Conception Unit, Glasgow Royal Infirmary, Scotland 
Main outcome measures: Plasma fatty acid concentrations, influence of twin pregnancies on DHA 
plasma concentration. 
Results: In pregnant women, there was a rapid, early increase in the maternal rate of change of plasma 
DHA concentration observed by 29 days post-LH surge (mean+SD, from 0.1+1.3 to 1.6+2.9 nmol 
DHA per mL plasma per day). This early pressure to increase plasma DHA concentration was further 
emphasised in twin pregnancies where the increase in DHA concentration over 45 days was two-fold 
higher than in singleton pregnancies (mean+SD increase, 74+39 nmol/mL versus 36+40 nmol/mL). 
An index of delta-6 desaturase activity increased 30% and positively correlated with the rate of 
change of DHA concentration between day 18 and 29-post LH surge (R-squared adjusted = 41%, 
P=0.0002). DHA was the only fatty acid with a continual accelerated increase in plasma concentration 
and a positive incremental area under the curve (mean+SD, 632+911 nmol/mL x day) over the first 45 
days of gestation.  
Conclusions: An increase in maternal plasma DHA concentration is initiated in human pregnancy 
prior to neural tube closure which occurs at 28 days’ gestation.   
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Introduction 
The long chain polyunsaturated fatty acids (LC PUFA), docosahexaenoic acid (DHA) and arachidonic 
acid (AA), are important in neurological development as these lipids are key membrane components 
of nervous tissues (1,2). The fetal-placental circulation is established around 9-13 weeks of gestation, 
after which the growing fetus preferentially acquires DHA and AA from maternal plasma via 
placental transport (3,4). In contrast, the essential dietary fatty acids linoleic acid (LA) and alpha-
linolenic acid (ALA), which are the precursors of LC PUFA, are at best minimally transferred to the 
fetus from maternal plasma (3,5). We have previously shown that maternal erythrocyte DHA 
concentrations (an indicator of the previous 3 months’ change in concentration) increased 17% by the 
end of the first trimester and continued to significantly increase throughout pregnancy to 26% above 
post-partum (non-pregnant) concentrations by the third trimester (6). AA concentrations did not 
change but the concentration of nervonic acid important in myelination, increased by 5% and 22% by 
the end of the first and third trimester respectively (6). Thus plasma concentrations of fatty acids 
essential for brain development are increased by the end of the first trimester and are available for 
placental transport to the fetus. 
 
The sources of LC PUFA for this increase in plasma concentration or “mobilisation” in pregnant 
women have not been fully identified and could include ingestion in maternal diet, maternal synthesis 
from shorter chain precursors or release from maternal membrane stores and adipose tissue. Our 
previous study suggested that ALA, but not LA, is mobilised for LC PUFA synthesis in pregnancy 
(6). Humans possess the necessary enzymes to metabolise these two precursor fatty acids to LC 
PUFA (Supplemental Fig 1). Healthy, non-pregnant individuals can convert LA to AA by 
desaturation (delta-6 desaturase /FADS2), elongation (ELOVL5) and further desaturation (delta-5 
desaturase/FADS1) in the liver (7). These same enzymes, in parallel, also convert ALA to 
eicosapentaenoic acid (EPA) and ultimately DHA but these conversions, particularly to DHA, are 
limited. Interestingly this pathway is more efficient in women than in men suggesting gender-specific 
roles for this pathway (8). The dominance of the omega-6 LC PUFA pathway can be explained by the 
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competition of LA and ALA for the same delta-6 desaturase enzyme, given that dietary LA intake is 8 
fold higher than that of ALA (9). 
 
The critical requirement of DHA for fetal brain development, and the poor efficiency of its synthesis 
in humans, is therefore a metabolic problem to be overcome in pregnancy. Furthermore, as the first 
primitive brain cells are formed by day 15 of gestation, neural tube closure occurs by 28 days’ 
gestation and the head of the embryo grows fastest in the early gestational weeks, we hypothesised 
that changes in maternal plasma LC PUFA concentration prior to 13 weeks’ gestation are vitally 
important. Unfortunately the direct assessment of maternal fatty acid changes from pre-pregnancy to 
the first weeks of gestation is difficult in a free living population, and there are no data on these 
earliest changes. Our aim therefore was to assess plasma fatty acid changes in very early pregnancy in 
a population of women undergoing natural cycle-frozen embryo transfer as a means of achieving 
accurately timed peri-conceptual sampling. 
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Methods 
Study design, setting and participants 
This prospective, observational study was conducted at Glasgow Royal Infirmary and was approved 
by the Local Research Ethics Committee (07/S0704/49). Women undergoing frozen embryo transfer 
(FET) treatment for infertility were recruited from the Assisted Conception Unit (ACU) between 
October 2007 and April 2010. Women were eligible for the study if they had a regular menstrual 
cycle. Patients that had ovulation stimulation or induction were excluded. No progesterone 
supplementation or other hormonal supplements were given. All women were recommended to take 
400µg per day of folic acid in line with World Health Organisation guidelines. Women were informed 
of the study when notifying the clinic nurse of their last menstrual period (LMP) date with a view to 
booking FET treatment. At day 10 after LMP (pre-luteinising hormone (LH) surge), the women 
attended the ACU to commence daily hormonal sampling to detect the LH surge and time embryo 
replacement. At this point women provided written informed consent and a basal blood sample. 
Embryo transfer was performed on day 3 post-LH surge. Information on patient demographics and 
fertility history was collected from patient notes. Patient height and weight data were collected at the 
pre-LH surge visit. Body mass index (BMI) was calculated as weight in kg divided by height in 
metres squared. Scottish Index of Multiple Deprivation (SIMD) quintile (10) was derived from patient 
postcode. 
 
Blood sampling 
Fasting blood samples were collected approximately day 10 after LMP (pre-LH surge) and on days 
18, 29 and 45 post-LH surge.  Plasma was collected by low speed centrifugation and frozen at -80°C 
within 2 hours. At day 18 post-LH surge the women who were not successful in getting pregnant 
withdrew from the study and therefore did not provide any blood samples at days 29 and 45 post-LH 
surge. 
 
Plasma analysis  
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Fatty acids were extracted from plasma and analysed as described in detail in the Supplemental 
Methods. 
 
Statistical analyses  
Data were tested for normal distribution using a Ryan Joiner test and log or square root transformed 
when necessary. Values for continuous biochemical variables are given as mean ± standard deviation 
(SD) or number (%) for categorical variables. The rate of change of fatty acids between time points 
was calculated as the difference between the fatty acid concentration at the second time point and at 
the first time point divided by the difference in time (days) between the two time points. The results 
are expressed as nmol/mL plasma per day. Incremental area under the concentration (pre-LH surge to 
45 days post-LH surge) x time curve (iAUC) were calculated using the trapezium method with 
correction for pre-LH surge parameter level (11). The results are expressed as nmol/mL x day. 
Differences in concentrations of fatty acids over time were assessed by one way ANOVA for repeated 
measures, with between group comparison using post hoc Tukey-Kramer HSD. Simultaneous 
difference testing between twin and singleton pregnancies across time points was carried out using a 
univariate split-plot approach repeated measures analysis with post hoc ANOVA for specific 
time/twin singleton pregnancy differences. Associations between variables were examined using 
univariate regression analysis. Prediction of successful pregnancy outcome at day 45 post-LH surge 
using 18 day post-LH surge data was assessed by univariate and multivariable logistic regression. 
Stepwise logistic regression was used to select variables to include in multivariable models with the 
significant levels to enter and stay in model set at p< 0.05. Results are reported as odds ratio (OR) 
[95% confidence interval (CI)], associated P-value and the C-statistic for the area under the curve. 
Odds ratios represent an increase of 1 unit unless otherwise stated for continuous variables. Statistical 
analyses were performed using the JMP statistical analysis program (Version 9.02, SAS Institute 
2010, Cary, NC, USA) or SAS (Version 9.2, SAS Institute, Cary, NC, USA) and statistical 
significance was set at  ≤0.05 for all analyses.   
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Results 
Study population 
A total of 196 FET cycles were started in the study, of which 161 were completed, from which there 
were 38 pregnancies: two were excluded as being a repeat attempt at FET treatment within the study 
and nine were excluded as they did not have complete data for all visits; therefore 27 pregnant women 
were included. From the 161 FET cycles completed, there were 123 failed pregnancies, of which 35 
had full fatty acid data (Supplemental Figure 2).  
 
Table 1 shows the demographic characteristics of the 27 pregnant women and 35 women not 
successful in getting pregnant and there were no significant differences between the two groups of 
women, except that use of ICSI was significantly more prevalent in the women who became pregnant. 
 
Plasma fatty acid concentrations over the first 45 days post-LH surge 
The baseline pre-pregnancy sample was taken at the time of sampling to identify the LH surge prior to 
the women receiving FET.  The mean time of this sample was 3 days prior to the LH-surge with a 
standard deviation of 3 and a range of minus 12 to plus 1 days relative to the LH surge. Plasma fatty 
acid concentrations over time are shown in Table 2. Palmitic, stearic and oleic acids concentrations 
were significantly reduced by 12-15% by day 18 post-LH surge but their concentrations returned back 
to pre-LH surge levels by day 45 post-LH surge. Lignoceric acid concentration was significantly 
decreased by 10% by day 29 and was sustained at day 45 post-LH surge. There was no change in AA 
but there was a trend for a 10% reduction in LA concentration by day 18 post-LH surge which was 
maintained at days 29 and 45 post-LH surge. Gamma-linolenic acid concentration was significantly 
decreased by 29% by day 18 post-LH surge and remained at that concentration at day 29 post-LH 
surge. Dihomo-gamma-linolenic acid, adrenic acid and omega-6 docosapentaenoic acid (DPA) 
concentrations were significantly increased by 19%, 36% and 71% respectively. There were no 
changes in plasma ALA and omega-3 DPA with time, but EPA concentration decreased by 29% by 
day 45 post-LH surge, although the post-hoc analysis did not result in significance. DHA 
concentration was significantly increased by 31% by day 45 post-LH surge. 
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The ratio of dihomo-ϒ-linolenic acid to LA is indicative of delta-6 desaturase activity.  The ratio of 
plasma dihomo-ϒ-linolenic acid to LA concentration (mean + SD) was 0.054 (0.012), 0.058 (0.011), 
0.060 (0.0113) and 0.070 (0.016) for pre-LH surge and days 18, 29 and 45 post-LH surge 
respectively. The increase in delta-6 desaturase was significant by day 45 post-LH surge (p=0.0002). 
In the women who were not successful in getting pregnant, there were no significant changes in 
plasma fatty acids from pre-LH surge to day 18 post-LH surge. 
 
Rate of change of plasma fatty acid concentrations and incremental area under the curve over the 
first 45 days post-LH surge 
The only plasma fatty acid with a continual increasing rate of change in concentration (Figure 1A) 
and a positive iAUC (Figure 1B) was DHA. The greatest rate of change in DHA was from day 18-29 
post-LH surge, when the rate of change of DHA concentration correlated significantly with an index 
of delta-6 desaturase activity; R-squared adjusted = 41%, P=0.0002 (Supplemental Figure 3).  Outside 
this time window, no such correlations were present (pre-LH surge to day 18; R-squared adjusted = -
4%, P=0.29: day 29 to 45 post-LH surge; R-squared adjusted = 0.1%, P=0.32). The other omega-3 
PUFA all had stable or decelerated rates of change in plasma concentration. ALA had a negative 
iAUC (Figure 1B) which could result from increased removal from the plasma compartment by being 
converted to EPA, DPA and DHA.  There was an initial decrease in the rate of change of plasma AA 
concentrations from pre-LH surge to day 18 post-LH surge which then switched to increased rates of 
change of plasma AA between day 18 and 45 post-LH surge (Figure 1A). However, overall there was 
no net change in AA concentration; the iAUC was zero (Figure 1B). Other major plasma fatty acids 
also initially showed declining rates of increasing plasma concentration from pre-LH surge to day 18 
post-LH surge which then switched to higher rates of increasing plasma concentration between day 
18-45 post-LH surge (Figure 2A), however their iAUC were all negative (Figure 2B) suggesting a 
loss of these fatty acids from the plasma compartment over 45 days. Of note is the rapid decline in 
plasma concentration and a corresponding large negative iAUC of LA, as a decrease in LA 
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concentration may allow delta-6 desaturase to favour DHA synthesis from ALA (Supplemental Figure 
1). 
 
Plasma DHA and omega-6 DPA concentrations over the first 45 days of gestation in twin pregnancies 
Increases in both DHA and omega-6 DPA concentrations were approximately two-fold higher in twin 
compared to singleton pregnancies (Table 3).  By day 45 post-LH surge DHA plasma concentration 
was significantly raised both in singleton and twin pregnancies and the increase from pre-LH surge 
levels was greater in twin (74nmol/mL) than singleton (36nmol/mL) pregnancies.  This two fold 
higher change in DHA concentration was also observed earlier at day 29 post-LH surge: twin (161-
131=30nmol/mL) versus singleton (163-149=14nmol/mL). The iAUC for DHA in twin pregnancies 
(1341+936nmol/mL over 45days) was significantly higher (P=0.013) than singleton pregnancies 
(384+781nmol/mL over 45 days). At day 29 post-LH surge omega-6 DPA change in concentration 
from pre-LH surge was three-fold higher in twin (2.4nmol/mL) versus singleton (0.8nmol/mL) 
pregnancy and two-fold higher at day 45 post-LH surge (7.4nmol/mL) versus (3.1nmol/mL) 
respectively. The iAUC for omega-6 DPA tended also to be higher in twin pregnancies 
(96+49nmol/mL over 45 days) than in singleton pregnancies (23+95nmol/mL over 45 days) but this 
did not reach significance (P=0.060). In a multivariate mixed model, plasma DHA levels were higher 
as gestation progressed (P<0.0001) but did not differ between twin and singleton pregnancy overall 
(P=0.97). A borderline significant interaction between days of gestation and twin pregnancy (P=0.06) 
suggests that DHA plasma concentration increases are higher in twins compared to singleton 
pregnancies in response to pregnancy (R-squared adjusted 83%). In a multivariate mixed model, 
plasma omega-6 DPA levels were associated with day of gestation (P<0.0001) and were higher 
overall in twin pregnancy (P=0.04). However, the non-significant interaction between days of 
gestation and twin pregnancy (R-squared adjusted 64%, P=0.10) provides less evidence that plasma 
omega-6 DPA concentration is increased to a greater extent in twin pregnancy. 
 
Linoleic acid and pregnancy outcome 
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There was a significant 10% reduction in plasma LA concentration between pre-LH surge and day 18 
post-LH surge in pregnant women (P=0.017) but not in women who were not successful in getting 
pregnant (P=0.63). Multivariable stepwise logistic regression analysis considering all day 18 post-LH 
surge variables (including erythrocyte fatty acid composition and insulin data not shown here) 
measured in women who became pregnant and those women who did not showed that at high insulin 
levels, low LA levels and high erythrocyte saturated fatty acid levels were associated with successful 
pregnancy at day 45 post-LH surge (C-statistic= 0.78) (Table 4). 
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Discussion and conclusion 
This study observed, for the first time, that uniquely among the fatty acids measured, DHA showed a 
net increase in concentration over the first 45 days of pregnancy with the highest rate of increase 
being observed after day 18 post-LH surge. This early pressure to increase plasma DHA concentration 
was further emphasised in twin pregnancies where the increase in concentration was double that in 
singleton pregnancies. A 14% increase in plasma volume at day 70 of gestation (12) suggests a 
change in plasma volume of 6% at day 18 post-LH surge and slightly higher (7%) in twin pregnancy 
(13). This increase in plasma volume cannot account for the differences in DHA concentrations 
observed here. The plasma fatty acids measured in this study reflect a complex mixture of fatty acids 
bound to albumin plus those fatty acids contained within lipoprotein particles, the transport of which 
is very complex requiring detailed isotope tracer kinetic studies which are beyond the scope of this 
study.  
The rapid and early increase in maternal plasma DHA concentration is consistent with our hypothesis 
that this fatty acid is of critical importance early in pregnancy. DHA, a major structural lipid in the 
brain, interacts with the plasma membrane protein syntaxin-3 which is required for the membrane 
fusion necessary for neurite outgrowth in developing neurons (14). Previous data has shown its 
importance during the latter stages of pregnancy when the brain accrues its tissue mass (15). Our data 
shows that DHA is also important during the very early stages of pregnancy when embryological 
nervous tissue is beginning to form. The timing of the increase in plasma DHA concentration is 
coincident with the time at which the very first primitive nerve cells appear and, by the time of neural 
tube closure at around 28 days’ gestation, the plasma concentration of DHA has increased 
significantly by 31% and a steady rate of increasing plasma concentration has been reached.  
The early rise in maternal plasma DHA concentration could be achieved either through its release 
from body stores or via increased synthesis. Diet is unlikely to be substantially changed over such a 
short period of time, but cannot be discounted. Humans do not store substantial amounts of DHA in 
adipose tissue, yet there is sufficient DHA content (16) and total adipose tissue mass in pregnant 
women that its release from adipose tissue could contribute to the increase in plasma concentration 
observed here. Another likely source is maternal de novo synthesis in the liver. The fractional 
13 
 
conversion rates of ALA to DHA in men is only 0.04% (17) with women being higher at 9% (8). Our 
observations that 1) the initial plasma concentrations of ALA and EPA decrease before rebounding 
between day 18-45; 2) the significant 10% reduction in plasma LA in pregnant women and 3) the 
accelerated increase in plasma concentration of DHA between day 18-29 post-LH surge was 
correlated with an index of delta-6 desaturase activity are all consistent with increased synthesis of 
DHA from its precursors. This agrees with observations in pregnant rats where plasma and liver DHA 
concentration as well as liver FADS2 (delta-6 desaturase) mRNA expression were increased by 
gestation day 20 (18). The increase in liver FADS2 mRNA expression was positively correlated with 
plasma concentrations of pregnancy hormones; oestradiol and progesterone (18), suggesting that these 
hormones are responsible for up-regulating DHA synthesis. The ability of women to convert more 
ALA to DHA has also been attributed to the presence of oestrogen (8) and post-menopausal women 
receiving oestrogen therapy have increased conversion (19). Low levels of LA have previously been 
shown to be associated with increased DHA levels in mothers in the third trimester and in their 
newborns (20), and this low placental transport of maternal LA allowed delta-6 desaturase activity to 
be directed more towards converting ALA to DHA (20).  Furthermore, the current study shows that 
low levels of LA is a predictor of successful pregnancy as indicated by positive fetal heartbeat at day 
45 post-LH surge. 
The substantial decrease in maternal plasma gamma-linolenic acid and the resultant increases in 
dihomo-gamma-linolenic acid and omega-6 DPA indicate that the synthesis of omega-6 DPA is 
important, as it can be used as a substitute when DHA supply is limited (21). In the eye, omega-6 
DPA is incorporated into rhodopsin-containing membranes when DHA concentration is low, albeit 
with a resultant reduction in visual acuity (22) and supplementation with DHA in infants may increase 
visual acuity (23). In DHA deficiency, omega-6 DPA is used in place of DHA in brain which appears 
to be a survival mechanism (24-26). Our observation of elevated omega-6 DPA, especially in twin 
pregnancy, may suggest a secondary mechanism to provide an alternative LC PUFA should there be 
insufficient DHA for neurological development at this critical time. 
Fatty acids in oocytes are primarily saturated fatty acids, oleic acid and virtually no omega-3 PUFA 
(27). Once an oocyte has been released from the ovary, the oocyte and any resultant embryo needs to 
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rely on its own energy source and oocytes express the relevant lipases to release fatty acids from 
triglyceride (28). Interestingly, inhibition of oocyte fatty acid oxidation in vitro reduces blastocyst 
formation and reduces the number of cells within each blastocyst (29). Thus, saturated fatty acids are 
key to successful embryo formation and implantation (30).  Sperm, on the other hand, contain 
predominately DHA (31), which upon fertilization of the oocyte, delivers at least some of the DHA 
needed for very early neurological development.  After implantation, the embryo must rely on fuels 
transported directly to the embryo from the mother until the fetal/maternal circulation is established at 
9-11 weeks of gestation. Our data show increased plasma concentrations of palmitic acid and oleic 
acid between day 18 and 45 post-LH surge, consistent with these fatty acids being used to meet the 
energy requirements by the embryo.  Exactly how the embryo obtains fatty acids from the maternal 
circulation is yet to be elucidated, but there is evidence for their simple diffusion across lipid vesicles 
(32). 
The strengths of this study were the prospective study design, with repeated within-individual 
sampling up to day 45 post-LH surge and the comprehensive analysis of fatty acid profiles measuring 
absolute concentrations. The main limitation of this study was that women undergoing in vitro 
fertilisation are not a “normal” pregnancy population and it should be noted that over 40% of the 
women were undergoing assisted conception due to problems with female fertility. However, the 
women had a natural menstrual cycle meaning there was no interference of exogenous hormones used 
in cycle reconstruction on their metabolic adaptation to pregnancy. Frozen rather than fresh embryos 
r BJ. Validation of an Australian electronic food frequency questionnaire to measure polyunsaturated 
ty acid intake.  advantage of the population used was the ability to get accurately timed peri–
conceptual and early pregnancy blood samples that would be extremely difficult to achieve from a 
free-living population. There was no dietary intake data, no information on morning sickness and due 
to being unable to collect relevant tissues, no direct measure of delta 6 desaturase activity and no 
assessment of embryo/fetal tissue accrual of fatty acids. Inferences on changes in fatty acid 
metabolism were made using serial steady state plasma fatty acid concentrations. While we can 
observe increases and decreases in plasma concentration, it does not fully establish whether these 
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changes in concentration were due to changes in rates of entry into or removal from plasma 
compartments as would be described by kinetic tracer studies which are clearly extremely difficult to 
perform in pregnant women. 
In conclusion, increases in maternal plasma DHA concentration occur very early in pregnancy 
highlighting the importance of DHA at this critical time when neural tube closure takes place. 
 
Acknowledgements 
B.J.M. and D.J.F. had full access to all of the data in the study and take responsibility for the integrity 
of the data and the accuracy of the data analysis. 
Funding 
D.J.F., R.J.B.N., H.L., S.M.N., N.S. were in receipt of a Wellbeing of Women project grant 
RG939/07. D.J.F. was in receipt of a Carnegie Award 2010, Harold Hyam Wingate Medical Research 
Travel Grant 2010. B.J.M. was in receipt of a University of Wollongong Study Leave Assistance 
Grant 2012. 
Author contributions 
D.J.F., R.J.B.N., H.L., S.M.N., N.S. and B.J.M. conceived and designed the study. C.C.O. and E.A.B. 
recruited subjects and collected patient data and samples. E.A.B., F.J., B.J.M and D.J.F. carried out 
biochemical and fatty acid analyses. Statistical analyses were carried out by B.J.M., D.J.F. and H.M. 
Manuscript was written by B.J.M. and D.J.F. with intellectual input and editing from C.C.O., R.J.B.N, 
N.S., H.L., H.M. and S.M.N. 
Author Information 
The authors declare no financial or other interests related to this study.  
  
16 
 
References 
 
1. Makrides M, Gibson RA. Long-chain polyunsaturated fatty acid requirements during 
pregnancy and lactation. Am J Clin Nutr 2000; 71:307S-311S 
2. Sattar N, Berry C, Greer IA. Essential fatty acids in relation to pregnancy complications and 
fetal development. Br J Obstet Gynaecol 1998; 105:1248-1255 
3. Al MD, van Houwelingen AC, Kester AD, Hasaart TH, de Jong AE, Hornstra G. Maternal 
essential fatty acid patterns during normal pregnancy and their relationship to the neonatal 
essential fatty acid status. Br J Nutr 1995; 74:55-68 
4. Montgomery C, Speake BK, Cameron A, Sattar N, Weaver LT. Maternal docosahexaenoic 
acid supplementation and fetal accretion. Br J Nutr 2003; 90:135-145 
5. de Groot RH, Hornstra G, van Houwelingen AC, Roumen F. Effect of alpha-linolenic acid 
supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status 
and pregnancy outcome. Am J Clin Nutr 2004; 79:251-260 
6. Stewart F, Rodie VA, Ramsay JE, Greer IA, Freeman DJ, Meyer BJ. Longitudinal assessment 
of erythrocyte fatty acid composition throughout pregnancy and post partum. Lipids 2007; 
42:335-344 
7. Bezard J, Blond JP, Bernard A, Clouet P. The metabolism and availability of essential fatty 
acids in animal and human tissues. Reprod Nutr Dev 1994; 34:539-568 
8. Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, 
docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002; 88:411-420 
9. Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PR. Dietary intakes and food 
sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003; 38:391-398 
10. Scottish Index of Multiple Deprivation 2004: Summary Technical Report. Edinburgh: 
Scottish Executive;2004. 
11. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in 
medical research. BMJ 1990; 300:230-235 
12. Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. Obstet 
Gynecol 2001; 97:669-672 
13. Thomsen JK, Fogh-Andersen N, Jaszczak P. Atrial natriuretic peptide, blood volume, 
aldosterone, and sodium excretion during twin pregnancy. Acta Obstet Gynecol Scand 1994; 
73:14-20 
14. Darios F, Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion 
by acting on syntaxin 3. Nature 2006; 440:813-817 
15. Innis SM. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J 
Pediatr 2003; 143:S1-8 
16. Mackay VA, Huda SS, Stewart FM, Tham K, McKenna LA, Martin I, Jordan F, Brown EA, 
Hodson L, Greer IA, Meyer BJ, Freeman DJ. Preeclampsia is associated with compromised 
maternal synthesis of long-chain polyunsaturated fatty acids, leading to offspring deficiency. 
Hypertension 2012; 60:1078-1085 
17. Burdge GC, Jones AE, Wootton SA. Eicosapentaenoic and docosapentaenoic acids are the 
principal products of alpha-linolenic acid metabolism in young men*. Br J Nutr 2002; 
88:355-363 
18. Childs CE, Hoile SP, Burdge GC, Calder PC. Changes in rat n-3 and n-6 fatty acid 
composition during pregnancy are associated with progesterone concentrations and hepatic 
FADS2 expression. Prostaglandins Leukot Essent Fatty Acids 2012; 86:141-147 
19. Ottosson UB, Lagrelius A, Rosing U, von Schoultz B. Relative fatty acid composition of 
lecithin during postmenopausal replacement therapy--a comparison between ethinyl estradiol 
and estradiol valerate. Gynecol Obstet Invest 1984; 18:296-302 
20. Novak EM, King DJ, Innis SM. Low linoleic acid may facilitate Delta6 desaturase activity 
and docosahexaenoic acid accretion in human fetal development. Prostaglandins Leukot 
Essent Fatty Acids 2012; 86:93-98 
21. Parletta N, Milte CM, Meyer BJ. Nutritional modulation of cognitive function and mental 
health. J Nutr Biochem 2013; 24:725-743 
17 
 
22. Niu SL, Mitchell DC, Lim SY, Wen ZM, Kim HY, Salem N, Jr., Litman BJ. Reduced G 
protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid 
deficiency. J Biol Chem 2004; 279:31098-31104 
23. Innis SM, Friesen RW. Essential n-3 fatty acids in pregnant women and early visual acuity 
maturation in term infants. Am J Clin Nutr 2008; 87:548-557 
24. Akbar M, Calderon F, Wen Z, Kim HY. Docosahexaenoic acid: a positive modulator of Akt 
signaling in neuronal survival. Proc Natl Acad Sci U S A 2005; 102:10858-10863 
25. Kim HY. Novel metabolism of docosahexaenoic acid in neural cells. J Biol Chem 2007; 
282:18661-18665 
26. Kim HY, Akbar M, Lau A, Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic 
acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J Biol Chem 2000; 
275:35215-35223 
27. Matorras R, Ruiz JI, Mendoza R, Ruiz N, Sanjurjo P, Rodriguez-Escudero FJ. Fatty acid 
composition of fertilization-failed human oocytes. Hum Reprod 1998; 13:2227-2230 
28. Cetica P, Pintos L, Dalvit G, Beconi M. Activity of key enzymes involved in glucose and 
triglyceride catabolism during bovine oocyte maturation in vitro. Reproduction 2002; 
124:675-681 
29. Ferguson EM, Leese HJ. A potential role for triglyceride as an energy source during bovine 
oocyte maturation and early embryo development. Mol Reprod Dev 2006; 73:1195-1201 
30. Tsai JH, Chi MM, Schulte MB, Moley KH. The fatty acid beta-oxidation pathway is 
important for decidualization of endometrial stromal cells in both humans and mice. Biol 
Reprod 2014; 90:34 
31. Tavilani H, Doosti M, Nourmohammadi I, Mahjub H, Vaisiraygani A, Salimi S, 
Hosseinipanah SM. Lipid composition of spermatozoa in normozoospermic and 
asthenozoospermic males. Prostaglandins Leukot Essent Fatty Acids 2007; 77:45-50 
32. Kampf JP, Kleinfeld AM. Is membrane transport of FFA mediated by lipid, protein, or both? 
An unknown protein mediates free fatty acid transport across the adipocyte plasma 
membrane. Physiology (Bethesda) 2007; 22:7-14 
 
18 
 
Figures and figure legends 
Figure 1A Rate of change of plasma polyunsaturated fatty acids from pre‐LH surge to 45 days post‐
LH surge 
 
Figure 1B Incremental area under the curve of plasma polyunsaturated fatty acids in 45 days 
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Figure 1A Rates of change (nmol/mL plasma per day) of maternal plasma polyunsaturated fatty 
acids. 20:4n-6 = —  —  —  —;  22:5n-6 = . . . .■ . . . ; 18:3n-3 =  - . -▲ .  - ; 22:6n-3 = ___X___.   
The rate of change of fatty acids were calculated as the difference between the fatty acid on day 18 
post-LH surge and pre-LH surge and then divided by the difference in time (days) between day 18 
post–LH surge and pre-LH surge. This was then repeated for all other time points, i.e. day 29 post-LH 
surge and day 18 post-LH surge and then day 45 post LH-surge and day 29 post-LH surge. The results 
are expressed as nmol/mL plasma per day. 
Figure 1B Incremental Area Under the Curve (nmol/mL plasma x day) of maternal plasma 
polyunsaturated fatty acids. 
Incremental areas under the time (pre-LH surge to 45 days post LH surge) x concentration curve were 
calculated using the trapezium method with correction for pre-pregnancy parameter level (11). 
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Figure 2A Rate of change of plasma fatty acids in from pre‐LH surge to 45 days post‐LH surge 
 
 
Figure 2B Incremental area under the curve of plasma fatty acids in 45 days 
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Figure 2A Rates of change (nmol/mL plasma per day) of the maternal major plasma fatty acids.    
18:2n-6 =—  —  —  — ; 18:1n-9 =  . . . .■ . . .; 16:0 = - . -▲ .  -;  18:0 =  ___X___; 
The rate of change of fatty acids were calculated as the difference between the fatty acid on day 18 
post-LH surge and pre-LH surge and then divided by the difference in time (days) between day 18 
post–LH surge and pre-LH surge. This was then repeated for all other time points, i.e. day 29 post-LH 
surge and day 18 post-LH surge and then day 45 post LH-surge and day 29 post-LH surge. The results 
are expressed as nmol/mL plasma per day. 
Figure 2B Incremental Area Under the Curve (nmol/mL plasma x day) of various maternal plasma 
fatty acids. 
Incremental areas under the time (pre-LH surge to 45 days post- LH surge) x concentration curve 
were calculated using the trapezium method with correction for pre-pregnancy parameter level (11). 
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Table 1. Demographic characteristics of study subjects. Values are mean and standard deviation 
(SD) for continuous variables or number (%) for categorical variables.  
 Pregnant women  
(n=27) 
Not successful in getting 
pregnant (n=35) 
P 
Age at FET (years) 34.7 (3.9) 33.5 (5.2) 0.33 
Smokers (number [%]) 3 (11)  8 (23) 0.25 
SIMD quintiles (number [%]) 
Affluent; Q1 & Q2 
Intermediate; Q3  
Deprived; Q4 & Q5 
 
10 (37) 
6 (22)  
11 (41) 
 
18 (52) 
5 (14) 
12 (34) 
 
0.32 
Number of previous pregnancies 
of ≥ 24 weeks’ gestation  
(number [%]) 
0, 1, 2 
 
 
 
20 (74), 4 (15), 3 (11)  
 
 
 
24 (71), 8 (24), 2 (6)* 
 
 
 
0.57 
Number of previous pregnancies 
of <24 weeks’ gestation  
(number [%]) 
0, 1, 2 
 
 
 
26 (96), 1 (4), 0 (0) 
 
 
 
33 (97), 0 (0), 1 (3)* 
 
 
 
0.25 
BMI (kg/m2) 26.2 (3.8) 26.4 (5.1) 0.88 
Systolic Blood Pressure (mmHg)  116 (15) 117 (12) 0.66 
Diastolic Blood Pressure (mmHg)  65 (7) 67 (9) 0.38 
Reason for Treatment 
Chem; Endo; Gen; Male;  
PA; PGD; Tubal; Unexplained 
 
0 (0); 3 (11); 0 (0); 15 (56); 
1 (4); 1 (4); 3 (11); 3 (11)* 
 
1 (3); 2 (6); 1 (3); 14 (40);  
0 (0); 0 (0); 13 (37); 4 (11)  
 
0.11 
Treatment 
IVF; ICSI 
 
8 (30); 19 (70) 
 
19 (58); 14 (42)* 
 
0.03 
Number of embryos transferred 
1, 2, 3 
 
4 (15), 22 (81), 1 (4) 
 
4 (12), 30 (88), 0 (0)* 
 
0.40 
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Twin pregnancy according to no. 
embryos transferred  
(number (%)) 
1, 2, 3 
 
 
 
0 (0), 7 (32), 0 (0) 
 
 
 
N/A 
 
BMI – Body Mass Index; Chem - Chemotherapy; Endo - Endometriosis; FET - frozen embryo 
transfer; Gen - Genetic; ICSI intra-cytoplasmic sperm injection; IVF – in vitro fertilisation; Male - 
Male infertility; N/A – not applicable; PA - Pelvic adhesion; PGD – preimplantation genetic 
diagnosis; Q – quintile; SIMD - Scottish Index of Multiple Deprivation.  
* missing data points 
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Table 2. Plasma fatty acid concentrations from pre-LH surge to 45 days post-LH surge in pregnant women (Preg, n=27) and women who were unsuccessful 
in getting pregnant (NP, n=35). Means (standard deviation) are shown. Differences between concentrations were tested using one way Analysis of Variance for 
repeated measures, across sampling from pre-LH surge (pre-pregnancy) to 18, 29 and 45 days post-LH surge and P values are given. NP women withdrew from the 
study after urine pregnancy testing at day 18 post-LH surge and therefore 29 and 45 days post-LH surge samples are not available (ns) for these women. Different 
superscript letters indicating differences between individual groups using post hoc Tukey-Kramer at significance level P<0.05. 
Fatty Acid* (nmol/mL) Pre-LHS 
Preg 
18 day post-
LHS Preg 
29 day post-
LHS Preg 
45 day post-
LHS Preg 
P  
Preg 
Pre-LHS 
NP 
18 day post-
LHS NP 
P  
NP 
SAFA 16:0 palmitic 2092 (346)a,b 1833 (333)a 1952 (394)a,b 2201 (453)b 0.004 1997 (437) 1998 (474) 0.92 
 18:0 stearic 620 (77) a 545 (87)b 552 (88)b 589 (99) a,b 0.0064 584 (89) 593 (102) 0.72 
 24:0 lignoceric 40 (6)a 38 (5)a,b 36 (4)b 36 (6)b 0.005 42 (7) 40 (6) 0.19 
MUFA 16:1n-7 palmitoleic 202 (79) 181 (86) 183 (69) 191 (76) 0.78 200 (104) 187 (89) 0.77 
 18:1n-9 oleic 1770 (338) a 1512 (377) b 1623 (411) a,b 1843 (467) a 0.010 1707 (460) 1787 (470) 0.48 
 24:1n-9 nervonic 88 (11) 88 (12) 85 (16) 92 (18) 0.26 93 (15) 94 (20) 0.89 
PUFAn-6  18:2n-6 linoleic 2569 (384) 2297 (422) 2353 (382) 2334 (420) 0.056 2533 (353) 2495 (367) 0.60 
 18:3n-6  ϒ- linolenic 45 (18)a 32 (13)b 32 (16)b 34 (12)a,b 0.0067 42 (21) 42 (23) 0.98 
 20:3n-6  dihomo-ϒ-
linolenic 
137 (31)a 130 (29)a 142 (36)a,b 163 (46)b 0.008 137 (33) 140 (33) 0.70 
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 20:4n-6  arachidonic 572 (108) 546 (103) 573 (134) 627 (154) 0.16 549 (106) 535 (118) 0.53 
 22:4 n-6 adrenic 12 (5) a,b 11 (4) b 12 (5) a,b 15 (5) a 0.016 12 (4) 11 (5) 0.67 
 22:5n-6  docosapentaenoic 7 (4)a 7 (4)a 9 (4)a,b 12 (5)b 0.0005 6 (4) 7 (5) 0.60 
PUFAn-3  18:3n-3  α-linolenic 68 (27) 57 (24) 57 (21) 68 (31) 0.26 66 (27) 70 (27) 0.52 
 20:5n-3 eicosapentaenoic 89 (47) a 69 (31) a 64 (27) a 63 (30) a 0.042 77 (43) 68 (31) 0.49 
 22:5n-3 docosapentaenoic 49 (15) 43 (13) 44 (17) 46 (19) 0.53 48 (15) 48 (14) 0.97 
 22:6n-3 docosahexaenoic  145 (47)a 146 (45)a 163 (48)a,b 190 (56)b 0.003 135 (55) 131 (49) 0.75 
LHS – luteinising hormone surge; MUFA - monounsaturated fatty acids; NP – not successful in becoming pregnant; Preg – successful pregnancy; PUFA - 
polyunsaturated fatty acids; SAFA - saturated fatty acids.  * Analysis was conducted on untransformed data except for the following: Log transformed – 14:0, 16:0, 
18:0, 16:1n-7, 18:1n-9, 24:1n-9, 18:2n-6, 20:3n-6, 20:5n-3, 22:5n-3, 22:6n-3. Square root transformed – 22:0, 24:0, 20:4n-6, 18:3n-3, 18:3n-6. 
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Table 3. Comparison of singleton versus twin pregnancy plasma 22:5n-6 and 22:6n-3 
concentrations from pre-LH surge to 45 days’ post-LH surge.  Mean (standard deviation) is 
shown. Differences between concentrations were tested using one way Analysis of Variance for 
repeated measures, across sampling gestations pre-LH surge and 18, 29 and 45 days post-LH surge 
and P values are given. Different superscript letters indicate differences between individual groups 
using post hoc Tukey-Kramer at significance level P<0.05. * analysis carried out on log transformed 
data. 
Fatty Acid 
(nmol/mL) 
pre-LH surge 
(pre-
pregnancy) 
18 days  
post-LH 
surge 
29 days  
post-LH 
surge 
45 days  
post-LH 
surge 
P 
 
Singleton (n= 20)/ 
Twin pregnancy (n= 7) 
     
22:5n-6 (S) 6.9 (4.9)a,b 5.9 (4.6)a 7.7 (4.1)a,b 10 (4.8)b 0.037 
22:5n-6 (T) 8.6 (2.2)a 8.5 (2.3)a 11 (2.8)a 16 (4.0)b 0.0002 
22:6n-3* (S) 149 (52)a 145 (48)a 163 (55)a 185 (61)a 0.093 
22:6n-3* (T) 131 (28)a 151 (37)a 161 (25)a,b 205 (38)b 0.0023 
LH – luteinising hormone; S, singleton pregnancy; T, twin pregnancy 
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Table 4. Univariate and multivariable logistic regression models of day 18 post-LH surge variables and pregnancy outcome at day 45 post-LH surge. 
Outcome was pregnant or not pregnant at day 45 post-LH surge. Covariates were selected using stepwise logistic regression models run for day 18 post-LH 
surge covariates individually significant (at P<0.05). Data shown are the univariate and multivariable odds ratio (for the given unit of change) and the 95% 
confidence interval, with the associated P-value, and the C-statistic (for the Area under the Curve). The multivariable model is a stepwise model with P-to-
enter and P-to-stay each set at 0.05.   
Covariate Univariate  
odds ratio  
(95% confidence 
interval) 
P C-statistic (Area 
Under Curve) 
Multivariable 
odds ratio 
(95% confidence 
interval) 
P C-statistic  
(Area under 
curve) 
Day 18 post-LH surge      0.78 
Log insulin  
(mU/L) 
2.05 (1.07, 3.92) 0.03 0.62 2.23 (1.01, 4.93) 0.048  
Plasma 18:2n-6  
(500 nmol/mL) 
0.44 (0.24, 0.82) 0.010 0.69 0.48 (0.24, 0.99) 0.046  
Erythrocyte saturated 
fatty acid (%) 
3.37 (1.60, 7.11) 0.0014 0.70 3.12 (1.41, 6.92) 0.0050  
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Outcome was pregnant or not pregnant at day 45 post-LH surge. Covariates were selected using stepwise logistic regression models run for day 18 covariates 
individually significant (at P<0.05). Data shown are the univariate and multivariable odds ratio (for the given unit of change) and the 95% confidence interval, 
with the associated P-value, and the C-statistic (for the Area under the Curve). The multivariable model is a stepwise model with P-to-enter and P-to-stay 
each set at 0.05.  
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Supplemental Material 
Supplemental Methods 
Plasma Fatty Acid Analysis 
Plasma samples were prepared according to Swierk et al (1). The direct transesterification procedure was 
implemented according to Lepage and Roy (2). Plasma fatty acid samples were analysed by flame-ionisation gas 
chromatography (model GC-17A, Shimadzu) using a 50m x 0.25mm internal diameter capillary column. One 
microlitre of the sample was auto-injected into the column, and individual fatty acids were quantified using the 
Shimadzu analysis software (Class-VP 7.2.1 SP1, USA). Fatty acid peaks were identified by comparison with 
known fatty acid standards and quantitated by comparison to the internal standard (Nu-chek and Sigma). 
 
Power Calculation and Statistical Analysis 
Power calculations for the original study to look at the impact of maternal BMI on maternal metabolic adaptation to 
pregnancy, from which the current study women were identified,  were based on projected differences in metabolic 
parameters between non-pregnant women (3 months’ post natal) and pregnant women in the first trimester using 
data from a previous longitudinal study of pregnancy (3). To detect the expected early pregnancy change in 
HOMA, between the bottom and middle BMI tertile, of 3.15 (3) with a standardised Sigma of 1.01, n=21 and n=27 
provided 80% and 90% power respectively.  
 
 
Supplemental Figure Legends 
 
Supplemental Figure 1. Mammalian polyunsaturated fatty acid synthetic pathways, showing how changes in 
concentrations of the key fatty acid intermediates observed in the study may explain an increase in DHA synthesis. 
 
Supplemental Figure 2. Consort diagram illustrating women enrolled in the study, showing unsuccessful and 
successful pregnancies as well as reasons for withdrawal and exclusions. 
 
Supplemental Figure 3. Delta-6 desaturase (measured by the ratio of 20:3n-6 to 18:2n-6 at day 29 post-LH surge) 
correlation with the rate of change of 22:6n-3 between 18 and 29 days post-LH surge (R2 adj = 0.41, P=0.0002). 
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Polyunsaturated Fatty Acid Synthesis Pathways 
(Mammalian) 
    Omega‐6 Pathway       Omega‐3 Pathway 
18:2n‐6 (linoleic acid)      18:3n‐3 (α‐linolenic acid) 
Delta 6 desaturase  
(FADS2) 
      18:3n‐6        18:4n‐3 
         Long chain fatty acid elongase 
            (ELOVL5) 
↑20:3n‐6        20:4n‐3 
          Delta 5 desaturase 
             (FADS1)  
    20:4n‐6 (arachidonic acid)    20:5n‐3 (eicosapentaenoic acid) 
                     Very long chain FA elongase 
            (ELOVL2) 
      22:4n‐6         22:5n‐3 (docosapentaenoic acid) 
       Very long chain FA elongase 
            (ELOVL2)           
24:4n6          24:5n‐3            
      Delta 6 desaturase 
 (FADS2) 
 
24:5n‐6         24:6n‐3                         
          β‐oxidation 
      ↑22:5n‐6        ↑22:6n‐3 (docosahexaenoic acid) 
 reduced conversion from 18:2n‐6 to 18:3n‐6 
 reduced levels of 18:3n‐6 
increased conversion of 18:3n‐6 to 20:3n‐6 
↑ increased levels of 20:3n‐6, 22:5n‐6 and 22:6n‐3 
Supplemental Figure 1 
 
   
 
Peroxisome 
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Supplemental Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
196 women with a 
natural menstrual cycle 
received FET 
35 withdrew 
- 3 withdrew consent 
- 25 cycles cancelled 
- 7 lost to follow up 
161 FET cycles 
123 failed 
pregnancies 
38 successful 
pregnancies 
2 excluded due to the  
FET not being their first  
attempt in this study 
35 failed pregnancies 
with full fatty acid data 
36 successful 
pregnancies 
27 successful  
pregnancies with  
full fatty acid data 
9 excluded due to  
lack of fatty acid data 
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Supplemental Figure 3 Delta-6 desaturase (measured by the ratio of 20:3n-6 to 18:2n-6 at day 29 
post-LH surge) correlation with the rate of change of 22:6n-3 plasma concentration between 18 and 29 
days post-LH surge (R2 adj = 0.41, P=0.0002). 
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